Arthneeti
Sale is live|00:00:00

UPL Ltd Q4 FY26 Earnings Analysis

Published 4 Jul 2026 | Fertilizers & Agrochemicals | Market Cap: ₹53.4K Cr

Price

607

Market Cap

₹53.4K Cr

P/E Ratio

28.2

Earnings Summary

- UPL expects full-year FY '26 revenue growth of 4% to 8% and EBITDA growth of 12% to 16%. - UPL maintains full-year FY '26 guidance with expectations of 4% to 8% revenue growth and 12% to 16% EBITDA growth.

📊 Revenue & Sales Performance

- UPL expects full-year FY '26 revenue growth of 4% to 8% and EBITDA growth of 12% to 16%. (Page 10) - The company anticipates volume-led growth in Q4, supported by in-season demand and higher revenues from new product launches. (Page 8) - New product launches are on track to exceed a $130 million revenue target in FY '26, with strong traction in Brazil and LATAM, expected to accelerate in Q4. (Page 9) - Regional growth expected in Q4 across all markets, including Europe, North America, Latin America, Africa, and Asia Pacific. (Pages 9-11) - North America’s growth expected to be stronger in Q4 due to delayed sales from Q3 and strong herbicide demand. (Page 11) - Sustainable solutions are scaling, delivering strong growth, particularly in Europe and Asia Pacific with 11% revenue growth in Q3. (Page 7) - Market cautiousness remains due to tariff uncertainty and trade issues, but overall momentum is positive. (Pages 7, 11)

📈 Profitability & Margins

- UPL maintains full-year FY '26 guidance with expectations of 4% to 8% revenue growth and 12% to 16% EBITDA growth. - Q4 anticipated to see growth across all regions, supported by strong in-season demand and new product launches. - Contribution margins expected to expand due to improved product mix, higher capacity utilization, and lower input costs. - Management confident in delivering strong Q4 results focusing on top line, bottom line, and cash generation. - EBITDA growth is strong year-to-date, with 22% growth over 9 months and margin improvements. - Profit before tax (PBT) increased significantly by 90% Y-o-Y in Q3, supported by reduced finance costs and improved joint venture performance. - The company aims for sustainable improvement in business quality and operational efficiency. - Earnings growth driven by volume expansion, new products, cost control, and debt reduction initiatives.

🏗️ Capital Expenditure Plans

- The document does not explicitly mention specific current or future capex or capital investment amounts. - There is a focus on strategic investments in new product launches, particularly in the crop protection segment, with a strong new product pipeline exceeding $130 million revenue target for new products this year. - Emphasis on operational excellence and manufacturing excellence contributing to cost reductions. - Advancement in sustainable solutions category with 11% revenue growth reflects strategic investment in this segment. - Advanta (seeds business) is undergoing corporate actions including IPO filing, indicating strategic investment in value unlocking and possible future capital allocation. - Management is investing selectively in SG&A towards growth and enterprise-wide transformation initiatives. - Debt repayment and deleveraging efforts indicate disciplined capital management but no direct mention of large capex outlays. - Overall, strategic focus appears to be on product innovation, market expansion, and ESG leadership rather than heavy capital expenditure.

💰 Fundraising & Capital Structure

- No explicit mention of new fundraising through debt or equity during the call. - Management emphasizes deleveraging with expected reduction in net debt-to-EBITDA ratio from 2.1x to between 1.6x-1.8x by March 2026, indicating net debt is expected to decrease rather than increase. - Upcoming debt maturities (e.g., $500 million in March 2026 and $400 million in September 2026) are planned to be met through operational cash flow, existing cash balances, and unutilized working capital lines. - IPO of Advanta is planned as an offer-for-sale, with cash proceeds going to existing shareholders (UPL and KKR) for deleveraging, not as a primary capital raise for Advanta. - Management is comfortable with cash position and options to handle capital structure as required but no mention of new debt or equity fundraising at this time.

📋 Order Book & Pipeline

The provided transcript from UPL Limited's Q3 & 9MFY26 earnings call does not explicitly mention current or expected order book or pending orders figures. However, some relevant information that implies strong demand and order momentum includes: - Strong momentum and confidence in Q4 performance, with growth expected across all regions. - January reinforced confidence due to solid order intake and customer engagement. - Record high prepay dollars in the U.S., indicating strong distributor commitments and order pipeline. - Strong in-season demand and higher revenues anticipated in Q4 from new product launches. - Supply chain readiness for a strong Q4, implying anticipated order fulfillment. - Overall cautious but positive outlook for revenue and EBITDA growth for the full financial year. No specific quantification of order book or pending orders is provided in the transcript.

Key Metrics

Frequently Asked Questions

What were UPL Ltd Q4 FY26 results?

- UPL expects full-year FY '26 revenue growth of 4% to 8% and EBITDA growth of 12% to 16%. - UPL maintains full-year FY '26 guidance with expectations of 4% to 8% revenue growth and 12% to 16% EBITDA growth.

What is UPL Ltd share price analysis?

UPL Ltd currently shows a neutral. The stock trades at a P/E of 28.2 with a market cap of ₹53,356. Investors should review the full earnings analysis for detailed insights.

Is UPL Ltd planning capital expenditure?

- The document does not explicitly mention specific current or future capex or capital investment amounts.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.